New Delhi, India

Vipan Dhall

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Piramal Enterprises Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vipan Dhall. Retrieved from https://idiyas.com/inventor/vipan-dhall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vipan Dhall: Innovator in Pharmaceutical Composition

Introduction

Vipan Dhall is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral compositions.

Latest Patents

Vipan Dhall holds a patent for an oral pharmaceutical composition of lurasidone and its preparation. This invention relates to a tablet that comprises the active ingredient lurasidone or its pharmaceutically acceptable salt(s) or solvate(s), along with one or more pharmaceutical excipient(s). The patent outlines a process for the preparation of this composition, showcasing Dhall's innovative approach to pharmaceutical formulations. He has 1 patent to his name.

Career Highlights

Vipan Dhall is currently associated with Piramal Enterprises Limited, a leading company in the pharmaceutical sector. His work at Piramal has allowed him to focus on developing advanced pharmaceutical solutions that cater to various medical needs.

Collaborations

Some of his notable coworkers include Tejas Shah and Milan B Agrawal, who have collaborated with him on various projects within the pharmaceutical domain.

Conclusion

Vipan Dhall's contributions to pharmaceutical innovation, particularly through his patent on lurasidone compositions, highlight his role as a key figure in the industry. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…